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Abstract
O-glycosylation of proteins in Neisseria meningitidis is catalyzed by PglL, which belongs to a protein family including WaaL
O-antigen ligases. We developed two hidden Markov models that identify 31 novel candidate PglL homologs in diverse
bacterial species, and describe several conserved sequence and structural features. Most of these genes are adjacent to
possible novel target proteins for glycosylation. We show that in the general glycosylation system of N. meningitidis,
efficient glycosylation of additional protein substrates requires local structural similarity to the pilin acceptor site. For some
Neisserial PglL substrates identified by sensitive analytical approaches, only a small fraction of the total protein pool is
modified in the native organism, whereas others are completely glycosylated. Our results show that bacterial protein O-
glycosylation is common, and that substrate selection in the general Neisserial system is dominated by recognition of
structural homology.
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Introduction
Protein glycosylation occurs in all domains of life, where it is
important in protein folding, stability and function. The presence
of bacterial glycoproteins has long been known, but recent years
have shown a dramatic increase in reports of protein glycosylation
in diverse bacteria [1,2]. Genes encoding these glycoproteins are
typically encoded in operons that include a glycosyltransferase and
a single acceptor glycoprotein. Several recent reports have
described general glycosylation systems in Gram-negative bacteria,
including Neisseria meningitidis [3], Neisseria gonorrhoeae [4], Campylo-
bacter jejuni [5,6] and Bacteroides fragilis [7]. In these general systems,
a single glycosyltransferase or oligosaccharyltransferase enzyme
modifies multiple different substrate proteins and the genes
encoding the enzyme and substrate proteins are typically not
closely linked on the genome.
The pathogenic N. meningitidis is the causative agent of
meningococcal meningitis and septicaemia and is a worldwide
health burden. N. meningitidis has a general system for protein O-
glycosylation, which modifies PilE (Pilin), the major adhesin of
N. meningitidis [8], and AniA, a surface exposed nitrite reductase
[3]. A model has been developed for protein O-glycosylation in
this system, which is similar to wzy-dependent O-antigen
biosynthesis in Gram-negative bacteria [9]. In this model, a
glycan to be transferred to protein is assembled on a diphosphate-
polyprenyl lipid carrier on the cytoplasmic face of the inner
membrane by the sequential action of glycosyltransferases PglB,
PglA, PglE and the acetyltransferase PglI. N. meningitidis can have
different repertoires of glycosyltransferases, with PglB2, PglG and
PglH also present in some isolates [10,11]. Alterations in glycan
structure can also occur by phase variation (the high frequency,
reversible ON/OFF switching of gene expression) of the glycosyl-
transferases [10]. This potential diversity in the presence of
glycosyltransferases leads to a corresponding diversity of potential
mature glycan structures that can be transferred to protein.
However, independent of the structure of the mature glycan, it is
flipped to the periplasmic face of the inner membrane by PglF and
then transferred to protein by the PglL O-oligosaccharyltransferase
(O-OTase) [12]. This O-OTase enzyme exhibits extreme glycan
substrate promiscuity, and is capable of transferring many
structurally unrelated substrates from a pyrophosphate-polyprenyl
carrier to protein, including the possible naturally occurring N.
meningitidis glycans, C. jejuni glycan and even peptidoglycan
subunits [13]. This promiscuity is presumably advantageous to
allow efficient transfer of the diverse naturally occurring Neisserial
glycans to facilitate immune evasion.
While the PglL O-OTase exhibits extreme glycan substrate
tolerance, its acceptor protein range is not so diverse. Although N.
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meningitidis PglL and its homolog in N. gonorrhoeae are general O-
OTases capable of glycosylating multiple substrate proteins, the
range of substrate proteins is limited. N. meningitidis has only two
reported glycoproteins, PilE and AniA [3]. PilE is an abundant
glycoprotein adhesin of N. meningitidis, and is glycosylated on
Ser63. This Ser is located in a folded domain with local sequence
Asn-Thr-Ser(glycan)-Ala-Gly. A second glycoprotein, AniA is
glycosylated in its low-complexity C-terminal region with up to
two Ser residues modified [3].
The key difference between wzy-dependent O-antigen biosyn-
thesis and PglL protein O-glycosylation is the acceptor substrate
specificity: oligosaccharide is transferred by the WaaL O-antigen
ligase to a terminal sugar of the LPS core, while the PglL O-OTase
transfers oligosaccharide to serine or threonine in a protein. While
WaaL and PglL catalyze reactions with clearly different biological
roles, it is not possible to differentiate the two groups of enzymes
using simple sequence based analyses such as BLAST [12].
Here, we describe the bioinformatic analysis of the PglL O-
OTase and the systematic identification of PglL homologs in other
bacterial species. We further characterized the protein acceptor
substrate requirements of N. meningitidis, which together provide
insights into the characteristics of general O-glycosylation systems
in bacteria.
Materials and Methods
Identification and Alignment of Homologues of PglL
The BLASTP programme was used to examine the NCBI non-
redundant protein database (http://www.ncbi.nlm.nih.gov/
BLAST/) for homologs of the protein glycosylation ligase of N.
meningitidis (PglL, NMA0800). 22 homologs, that were unique
protein sequences from each genus, were downloaded (PIDs
15676501, 34499662, 153886317, 76809217, 50083393,
153886318, 126665137, 121611683, 91790502, 126643191,
124265256, 120613309, 86147861, 89900058, 148977877,
121609153, 120609538, 89075308, 119944149, 15891610,
150377063, 51245303, 110807324, 77958742, 145298462). Clus-
talW alignment of these proteins identified two regions that were
well conserved in the putative PglL proteins and not in the WaaL
proteins (O-antigen ligases). The first region, termed PglL_A, was
25 amino acids (equivalent to amino acid 395 to 420 of
NMA0800) and the second, termed PglL_B, was 30 amino acids
(equivalent to amino acid 171 to 201 of NMA0800). A HMM was
generated from a ClustalW alignment of both of these regions in
the above proteins using the program hmmbuild, followed by
hmmcalibrate [14]. Membrane spanning regions of proteins were
predicted using Phobius V 1.0 (http://phobius.sbc.su.se/) [15].
The graphical representation of the Phobius model was created
with TMRPres2d [16].
Bacterial Strains and Culture Conditions
Acinetobacter baylyi strain ADP1 and Escherichia coli strain DH5a,
used to propagate cloned plasmids, were grown at 37uC in LB
broth or on LB solid agar. N. meningitidis strains were grown on
brain heart infusion medium (BHI) supplemented with Levinthal’s
base. N. gonorrhoeae strains were grown on GC media with
IsoVitaleX. Media was supplemented with appropriate antibiotics.
DNA Isolation and Manipulation
Genomic DNA of A. baylyi strain ADP1 was used as template in
a PCR reaction to amplify the pglL homolog (accession number
ACIAD3337). The product was cloned into the pT7Blue vector,
linearized with restriction endonuclease StyI, blunted and ligated
to the kan resistance cassette, excised from pUC4kan with HincII.
Transformation of ADP1 was based on previously described
methods [17]. Shuttle vector pWH1266 [18] was used to
complement the ADP1pglL::kan mutant. The wild type ADP1 pglL
gene including 61 bp of the upstream region was amplified by
PCR, digested by BamHI and inserted into vector pWH1266 at
the BamHI site. The resulting plasmid, pWH1266-pglL, and
pWH1266 were separately transformed into the ADP1pglL::kan
mutant by electroporation. Previously described plasmid encoding
FLAG-tagged AniA and TetMB [3] was used as template for site-
directed mutagenesis to construct AniA variants [19]. Linearized
plasmid was transformed to the chromosome of C311 by
homologous recombination as described [3]. N. gonorrhoeae
MS11pglL::Kan strain was constructed as described [12].
Immunological Assays
Western blotting was performed essentially as previously
described [9]. Primary antibodies used were rabbit a-trisaccharide
sera [9] and mouse a-FLAG mAb (Sigma-Aldrich). a-ComP (A.
baylvi), and a-CcoP, a-MetQ, a-Sco, a-Mip and a-Laz (N.
meningitidis) antibodies were produced by inoculating mice with
the peptide-conjugated Keyhole Limpet Hemocyanin (synthesized
by Mimotopes, Australia). The conjugated peptide sequences
corresponding to the target proteins are shown in Table S1.
Secondary antibodies used were anti-rabbit IgG and anti-mouse
IgG (Sigma-Aldrich and Rockland). Cell lysates of wild-type and
mutant strains of A. baylyi were prepared from cells in late
stationary growth phase, when ComP expression is maximal [20].
Protein Immunoprecipitation and Purification
N. meningitidis C311 cells were harvested and resuspended in
TBSt (Tris buffered saline with 0.05% Tween-20) supplemented
with protease inhibitor cocktail (Roche). Cells were heat killed by
incubation at 56uC for 1 h, lysed by French press and debris
removed by centrifugation at 18,000 rcf for 10 min and filtration
through 0.22 mm filters. a-Glycan dynabeads for immunoprecip-
itation were prepared using rabbit polyclonal sera against the N.
meningitidis C311 O-glycan [9] or isotype negative control antisera,
and ProtA dynabeads (Invitrogen) according to the manufacturers
instructions. Clarified cell lysate was applied to the a-glycan
dynabeads and incubated with shaking at 25uC for 1 h. The a-
glycan dynabeads were washed thrice with 1 mL TBSt and eluted
with 200 mL (Glycine HCl pH 3 with 0.1% Tween-20). FLAG-
tagged AniA proteins were purified as described [3].
Mass Spectrometry
Purified AniA-FLAG protein was precipitated by addition of 4
volumes of 1:1 acetone:methanol, incubation at 220uC for 16 h
and centrifugation at 18,000 rcf for 10 min. The pellet was
washed with acetone:methanol, dried, resuspended in 50 mL
50 mM NH4HCO3 with 1 mg trypsin (proteomics grade, Sigma)
and digested at 37uC for 3 h. Peptides and glycopeptides were
analysed by LC-ESI-MS/MS with an API QSTAR Pulsar i LC/
MS/MS system, and MS data was analysed as described [3].
Differences in glycosylation occupancy between AniA variant
proteins were compared using a 2-sided Mann-Whitney test.
Immunoprecipitated eluted proteins were reduced/alkylated and
digested as above. Peptides were desalted with C18 ZipTips
(Millipore) and analysed by LC-ESI-MS/MS using a nanoLC
(Shimadzu) and TripleTof 5600 mass spectrometer (ABSciex) as
described [21]. Peptides were separated on a C18 column
(VYDAC), with a gradient from buffer A (0.1% formic acid) to
buffer B (80% acetonitrile with 0.1% formic acid). Data was
exported from.wiff format to.mgf format, and searched with
MASCOT V2.3 at the Australian Proteomics Computational
Bacterial O-Glycosylation Enzymes and Substrates
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Facility (http://www.apcf.edu.au/). Search parameters were:
enzyme, trypsin with up to 1 missed cleavage; fixed modifications,
cysteine propionamide; variable modifications, methionine oxida-
tion and asparagine deamidation; peptide tolerance, 0.05 Da;
MS/MS tolerance, 50 mmu; LudwigNR database (as at 2
November 2011; 15,321,871 sequences; 5,325,977,554 residues)
limited to N. meningitidis and common contaminants (28,591
sequences).
Circular Dichroism Spectroscopy
CD spectroscopy of synthesized peptide (NGAAPAASAPAA-
SAPAASASEKSVY; Auspep) in 50 mM potassium phosphate
buffer at pH 6.5 buffer was performed using a Jasco J-710
spectrometer as described [22]. The data were collected in the
wavelength range 190–269 nm at room temperature. The scan
speed was set to be 100 nm/min and the bandwidth was 0.5 nm.
Spectra were also obtained from solutions that contained the
peptide in 10%, 20%, 30%, 40% and 50% trifluoroethanol (TFE).
Molecular Modelling
Modelling of the amino acid sequence corresponding to the
glycosylated region (57WPGNNTS (Gal(b1–4)Gal(a1–3)2,4-diace-
timido-2,4,6-trideoxyhexose) AGVASSSTIK73) of C311#3 pilin
was calculated and modelled by Chemdraw and DYANA. The
two ends of the peptide (W57 and K73) were constrained 19.7 Å
apart as in the corresponding region of N. gonorrhoeae pilin
according to its published pili crystal structure [23].
Results
Creation of Hidden Markov Models to Distinguish
between PglL and WaaL Candidates
To identify PglL homologs in bacterial genomes we developed a
hidden Markov model (HMM) that would resolve the subset of
PglL protein O-OTases from the wider PFAM PF04932, which
contains both WaaL O-antigen ligases and PglL proteins. This
family of enzymes has low overall amino acid similarity but
contains a small region of conservation that is the basis for PFAM
PF04932. To identify sequence features which accounted for the
protein acceptor substrate specificity of PglL, we performed multi-
sequence alignments of protein sequences of close homologues of
PglL and used conserved features not present in WaaL to create
two HMMs, pglL_A and pglL_B (Fig. 1). HMM pgl_A has been
submitted to the Pfam database with accession number PF15864.
These HMMs did not identify well-characterized WaaL proteins
from enteric organisms, suggesting that they may be useful for the
identification of PglL candidates in wider searches.
Identification of PglL Homologs in Bacterial Genomes
The pglL-A HMM was used to search the NCBI non-redundant
protein database to identify candidate PglL O-OTases (Table 1).
Similar results were obtained with the pglL_B search. This analysis
identified PglL homologs in 31 distinct Gram-negative bacterial
species. These included pathogens such as Burkholderia, Vibrio,
Yersinia, Aeromonas and Acinetobacter, and several non-pathogenic
environmental species including Polaromonas, Rhodoferax and
Methylibium.
Examination of the genome location of these pglL homologs
revealed that in the majority of cases (21/31) they were
immediately adjacent to or closely associated with a gene(s)
encoding type IV pilin homologs (Table 1, Fig. 2). The close
association of the pglL O-OTase with an obvious target glycopro-
tein in so many cases suggests that the HMM analysis identified
both the glycosylation pathway and target acceptor protein. A
further indication that the genes identified are PglL rather than
WaaL homologs is that they are not located within LPS
biosynthetic loci [24].
The PglL_A and PglL_B motifs are located on either side of the
Wzy_C motif common to both PglL and WaaL, and represent
conserved regions on predicted periplasmic loops of PglLNm and
adjacent transmembrane regions. This suggests they have an
important structural or functional role in PglL activity. Three
residues important for the function of E. coli WaaL [25] located in
the Wzy_C motif are also conserved amongst PglLs (E. coli WaaL
R288, H338 and R215; N. meningitidis PglL R298, H349, R224).
We also identified additional residues conserved in PglLs but not
in WaaL (N. meningitidis PglL Q178, N180, G316, G318, H400,
E404, P406) and residues conserved in both PglLs and WaaL (N.
meningitidis PglL P313).
Experimental Confirmation of O-OTase Activity in a pglL
Homolog from Acinetobacter Baylyi
We tested the hypothesis that the pilin homologs closely
associated with the PglL O-OTase candidates were the cognate
target glycoproteins. In A. baylyi strain ADP1, the pglL gene
(accession number ACIAD3337) is adjacent to the comP gene
(ACIAD3338) which encodes a pilin-like protein which is essential
for natural transformation and has previously been shown to be
glycosylated [20]. However, the mechanism of glycosylation of
ComP has not previously been investigated. We created a
knockout mutant in the pglL gene of A. baylyi strain ADP1, and
complemented this mutant strain with expression of plasmid-borne
native pglL. Western blot analysis of extracts from the wild-type
ADP1 and ADP1pglL::kan mutant strains using an a-ComP
antibody indicated the presence of the 20 kDa glycosylated ComP
protein in the wild-type strain and a shift in MW to the 18 kDa
non-glycosylated form of ComP in the mutant strain (Fig. 3),
consistent with the loss of glycosylation of this protein. This
glycosylation could be partially rescued by complementation with
native pglL, but not with empty vector. This validated the role of
the PglL homolog in glycosylation of the ComP pilin-like protein
in strain ADP1.
General PglL Glycosylation Systems
The genomic localization of pglL close to substrate glycoproteins
in most bacteria suggested that these substrates were the key
targets for glycosylation (Table 1, Fig. 2). However, several pglL
homologs were detected not genomically associated with an
obvious glycoprotein substrate, including in the pathogenic
Neisseria known to possess general glycosylation systems. Since
genes that are not genomically linked cannot be co-transcribed, we
anticipated that additional mechanisms based on enzyme-
substrate recognition would also enhance glycosylation efficiency
in these bacteria. We therefore used N. meningitidis as a model
system to investigate the substrate requirements for modification in
this genomically unlinked system.
Several PglL substrate glycoproteins in addition to PilE and
AniA have been reported in N. gonorrhoeae [4]. However, Western
blotting using our a-glycan antisera failed to detect bands in
addition to AniA and PilE in N. meningitidis C311 whole cell
extracts [3]. To investigate if other glycoproteins were also present
in N. meningitidis C311, we performed IP of whole cell extracts
using a-glycan antisera, and identified eluted proteins with mass
spectrometry. a-Glycan co-IP identified three proteins: PilE,
azurin and MetQ (Fig. S1, S2 and S3; Tables S2, S3, S4 and
S5). These proteins were not identified by negative control IP with
unrelated rabbit antisera, suggesting that they were glycoproteins.
To validate the glycosylation status in N. meningitidis of azurin and
Bacterial O-Glycosylation Enzymes and Substrates
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MetQ, as well as selected other reported N. gonorrhoeae glycopro-
teins [4], we performed western blotting with protein-specific
antisera for each candidate glycoprotein. This showed that AniA,
Sco, CcoP and Mip were glycosylated in N. meningitidis C311 and
N. gonorrhoeae MS11, as they displayed clear MW shifts upon
genomic deletion of the PglL O-OTase (Fig. 4A,D,E,F). However,
MetQ and Laz failed to show clear changes in MW in the presence
and absence of glycosylation (Fig. 4B,C). This phenotype was also
observed in N. meningitidis MC58, and in N. gonorrhoeae 1291 and
O1G1370. Homologs of all of these proteins had been identified as
glycoproteins in N. gonorrhoeae [4]. Together with our a-glycan IP
results, this suggests that although glycosylated forms of MetQ and
Laz can be detected by MS [4], the major fraction of these
proteins in the cell under the conditions tested is not in fact
glycosylated.
Characteristics of Efficiently Glycosylated PglL Protein
Acceptor Substrates
The protein substrates of N. meningiditis PglL were either
predominantly glycosylated or predominantly non-glycosylated.
PilE, AniA, Sco, CcoP and Mip were completely glycosylated, as
their non-glycosylated forms were not detectable by western blot in
wild type Neisseria. Laz and MetQ were minimally glycosylated, as
their glycosylated forms were not detectable by western blot, but
rather only by MS analysis after glycan-specific enrichment. To
determine the details of this substrate specificity, we examined the
N. meningitidis glycoprotein AniA, which has been shown to be
glycosylated with up to two glycans in its C-terminal flexible
domain within the glycopeptide L358SDTAYAGNGAAPAASA-
PAASAPAASASEK387 [3]. No additional sites of glycosylation
were detected by this MS analysis [3]. We first tested if AniA had
additional glycosylation sites by analysing a FLAG-tagged AniA
variant with this 36 amino acid C-terminal flexible domain deleted
after Met354. Western blot analysis of FLAG-tagged full-length
wild type and C-terminally truncated variant AniA using a–FLAG
sera detected both variants, but a–glycan sera only detected full
length AniA (Fig. S4). This indicated that no additional
glycosylation sites were present in the core nitrite reductase or
flexible N-terminal domains of AniA.
We identified the precise sites of glycosylation in the Leu358-
Lys387 glycopeptide by site-directed mutagenesis and LC-ESI-
MS/MS analysis of peptides and glycopeptides from purified
variant glycoproteins. The extent of glycosylation is likely under-
estimated by this MS analysis due to reduced ionisation efficiency
of the glycosylated peptides relative to their unglycosylated forms.
Nonetheless, relative quantification of glycosylation occupancy is
possible with this analysis [26,27]. Up to two sites of glycosylation
were detected in wild type AniA (Fig. 5A, Fig. S4 and [3]). As this
Figure 1. N. meningitidis PglL topology and conservation. (A) Transmembrane profile of N. meningitidis PglL with the regions identified by the
PglL_A, PglL_B and Wzy_C hidden Markov models indicated by red, green and blue lines and highly conserved amino acids coloured in red and
orange. (B) The PglL protein Phobius transmembrane helix prediction with predicted transmembrane regions represented by dashed-lines. (C)
CLUSTALX plot of sequence conservation of CLUSTALW alignment of the putative PglL proteins. (D) Regions identified by the PglL_A, PglL_B and
Wzy_C hidden Markov models indicated by red, green and blue boxes respectively.
doi:10.1371/journal.pone.0062768.g001
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sequence included two identical repeats of the local sequence Ala-
Ala-Ser-Ala-Pro, encompassing Ser373 and Ser378, we created
AniA variants with each of these Ser residues individually mutated
to Ala (Table S6). LC-ESI-MS/MS analysis of both of these
variants showed loss of a single efficiently modified glycosylation
site, as these variants showed very low levels of di-glycosylated
peptide (Fig. 5B,C,F). Further, a variant with both Ser373Ala and
Ser378Ala mutations showed loss of both efficiently used
glycosylation sites, as essentially only un-glycosylated peptide was
identified (Fig. 5D,F). This confirmed that the two Ser residues
present in the local sequence Ala-Ala-Ser-Ala-Pro (Ser373 and
Ser378) were efficiently glycosylated by PglL. Several other Ser
residues are present in the Leu358-Lys387 glycopeptide, and of
particular note were the residues present in an imperfect repeat
reminiscent of the efficiently glycosylated sites, Ala-Ala-Ser383-
Ala-Ser385-Glu. The local sequence context of Ser383 differed
from the efficiently glycosylated Ser373 and Ser378 only by having
the sequence Ser383-Ala-Ser rather than Ser373/8-Ala-Pro. We
tested if this local sequence influenced glycosylation by creating a
Ser385Pro AniA variant in a Ser373Ala, Ser378Ala background.
Indeed, this AniA-Ser373Ala, Ser378Ala, Ser385Pro variant
showed significantly increased glycosylation compared with the
Ser373Ala, Ser378Ala control, with substantial mono-glycosylated
peptide detected (2-sided Mann-Whitney test, P= 0.01, Fig. 5E,F).
To investigate the structure of the AniA glycosylation acceptor
sites, we performed circular dichroism (CD) spectroscopy to
characterize the secondary structure of a synthesized peptide
corresponding to the unglycosylated AniA glycopeptide. The CD
spectrum of AniA in phosphate buffer showed substantial negative
ellipticity centred at 198 nm (Fig. 6A), indicative of an unstruc-
tured conformation. The glycosylation site in PilE (NTS63(glyca-
n)AG) is part of a short a-helix located in the so called ‘ab loop’
Table 1. Proteins matching HMMs pglL_A with a score greater than 20.
PID: Score E value Species Genetic context*
91790502 51.6 1.60E-09 Polaromonas sp. JS666 pilin, 2
89900058 49.3 7.90E-09 Rhodoferax ferrireducens T118 pilin
126643191 48.6 1.30E-08 Acinetobacter baumannii ATCC 17978 pilin
120613309 47.7 2.40E-08 Acidovorax avenae subsp. citrulli AAC00-1 pilin
121611683 47.3 3.20E-08 Verminephrobacter eiseniae EF01-2 pilin
84394373 47 3.90E-08 Vibrio splendidus 12B01 EA
148977877 47 3.90E-08 Vibrionales bacterium SWAT-3 EA
50083393 46.7 4.90E-08 Acinetobacter sp. ADP1 GalE, Pmm
59800633 46.3 6.40E-08 Neisseria gonorrhoeae FA 1090 hypothetical membrane protein
15793774 46.3 6.40E-08 Neisseria meningitidis hypothetical membrane protein
124265256 45.9 8.30E-08 Methylibium petroleiphilum PM1 pilin
119944149 45.8 9.20E-08 Psychromonas ingrahamii 37 E, transglycosylase SLT domain protein
126665137 44.9 1.70E-07 Marinobacter sp. ELB17 pilin
86147861 44.6 2.10E-07 Vibrio EA
121609153 43.6 4.30E-07 Verminephrobacter eiseniae EF01-2 acyltransferase 3, ribonuclease II
21672281 42.7 7.90E-07 Aeromonas hydrophila wzz
121532578 42.3 1.00E-06 Ralstonia pickettii 12J pilin
90412963 40.2 4.30E-06 Photobacterium profundum 3TCK EA
17545278 39.6 6.80E-06 Ralstonia solanacearum pilin
51245303 39.5 7.20E-06 Desulfotalea psychrophila LSv54 pilin
77979651 39.2 8.60E-06 Yersinia intermedia ATCC 29909 pilin
134279817 38.3 1.60E-05 Burkholderia pseudomallei 305 pilin
53724725 38.3 1.60E-05 Burkholderia mallei ATCC 23344 pilin
76809217 38.3 1.60E-05 Burkholderia thailandensis E264 pilin
153886317 38.2 1.80E-05 Ralstonia pickettii 12D pilin, 2
34499662 38 1.90E-05 Chromobacterium violaceum ATCC 12472 pilin, 2
149911011 37.8 2.30E-05 Moritella sp. PE36 EA
123441130 36.6 5.30E-05 Yersinia enterocolitica 8081 pilin
77958742 36.6 5.30E-05 Yersinia bercovieri ATCC 43970 pilin
91790501 36.2 6.80E-05 Polaromonas sp. JS666 pilin, 2
121595941 35.9 8.40E-05 Acidovorax sp. JS42 cytochrome c
90407310 35.9 8.80E-05 Psychromonas sp. CNPT3 EA
121606830 35.8 9.50E-05 Polaromonas naphthalenivorans CJ2 pilin
*Genetic context: EA, pglL between homologues of a exonuclease ABC subunit A and aminotransferase class V; pilin, a type IV pilin homologue, pilin 2, two closely
associated pilin homologues; E, exonuclease ABC subunit A; other genes are described by their homology or commonly known gene names.
doi:10.1371/journal.pone.0062768.t001
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[23], so to investigate if the AniA peptide in solution samples an
energy landscape that contains transiently structured conforma-
tions we obtained CD spectra in the presence of increasing
concentrations of TFE, which allows peptide intramolecular
hydrogen bonds to form by limiting competing bond formation
with solvent water. The CD spectra showed that increasing TFE
caused loss of negative ellipticity at 198 nm with a corresponding
increase in negative ellipticity around 225 nm (Fig. 6). Subtraction
of the spectrum of the AniA peptide in 0% TFE from that in 50%
TFE resulted in a spectrum with positive ellipticity at 195 nm and
a broad negative peak centred on 220 nm (Fig. 6B). These features
are suggestive of a helical conformation, but we note that even in
50% TFE the AniA peptide was still predominantly unstructured.
NMR analysis (Fig. S5) of the AniA peptide in the absence of TFE
showed that most amide protons had chemical shifts clustered
between 8.1 ppm and 8.3 ppm; Val24 and Tyr25 were shifted
upfield due to Tyr ring current effects. In agreement with the CD
results, the NMR result was indicative of an unstructured
conformation. The presence of increasing concentrations of TFE
showed a corresponding increase in the dispersion of amide
chemical shifts (both upfield and downfield shifts were observed)
suggesting that some residues adopted a structured conformation.
Discussion
Post-translational modifications of bacterial proteins are difficult
to identify and a bioinformatic means of identifying potential
glycosylation systems and their targets would enable the
characterisation of many more systems. PglL proteins in particular
have been difficult to identify due to the relatively low levels of
homology between members of this family and the overlap in
similarity to WaaL O-antigen ligases. Previously, PglL O-OTases
have been identified by homology with known WaaL/O-OTases
and the presence of the Wzy_C motif common to these distinct
functions [12], and then O-OTase function distinguished from
WaaL O-antigen ligase function by experimentation using
mutagenesis of the putative gene or cloning and expression in a
recombinant system [28]. In the current study we identified two
conserved motifs (PglL_A and PglL B) that are found in PglL
homologs but not in WaaL O-antigen ligases (Fig. 1). In silico
analysis using these motifs identified pglL genes in diverse Gram-
negative bacteria, showing that bacterial protein glycosylation
systems are much more common than previously appreciated. The
PglL homolog we identified from Y. enterocolitica (Table 1) (Ye777;
waaLXS; protein accession 123441130) has been studied in Y.
Figure 2. Genomic arrangement of selected pglL genes. Schematic representation of the regions of the genome containing pglL genes in
Neisseria meningitidis, Acinetobacter sp., Shigella flexneri and Ralstonia eutropha.
doi:10.1371/journal.pone.0062768.g002
Bacterial O-Glycosylation Enzymes and Substrates
PLOS ONE | www.plosone.org 6 May 2013 | Volume 8 | Issue 5 | e62768
enterocolitica and in E. coli for a role in LPS biosynthesis. Y.
enterocolitica encodes three WaaL homologs, and while all three
could complement LPS biosynthesis with deletion of E. coli waaL,
Ye777/waaLXS was not involved in LPS biosynthesis in the native
organism Y. entercolitica [29]. This is consistent with Ye777/waaLXS
being a protein O-OTase, as previously speculated [29] and as
predicted by our HMM analysis. During the preparation of this
manuscript, PglL-like O-OTase BTH_I0650 of B. thailandensis [30],
VC0393 of V. cholerae [30] and A1S_3176 of A. baumannii [31] were
identified by homology with Neisseria PglL and the presence of the
Wzy_C motif followed by experimentation to rule out a WaaL
function. Our HMM analysis predicted that these genes were PglL
homologs (Table 1), providing further support for our analysis.
The bioinformatic approach described herein efficiently predicts
many other such protein O-glycosylation systems.
In P. aeruginosa, the PilO system glycosylates pilin via the
addition of a single unit of the LPS O-antigen repeat [32]. The
pilO gene is adjacent to the pilin gene and in the same orientation,
however, the PilO O-OTase, despite sharing similarity with PglL
of Neisseria and O-antigen ligases, does not contain the PglL motifs
we describe here. Indeed, examination of protein databases does
not reveal homologs with a high degree of similarity to PilO
outside of the P. aeruginosa species suggesting that PilO might have
a slightly different mode of action to the PglL family.
The pglL gene and the gene encoding its presumptive target
protein are often found in the same orientation and in close
proximity, which suggests they are co-transcribed. This may
increase protein co-localisation and thereby increase the efficiency
of the glycosylation reaction. However, the requirement of
genomic co-localisation is not absolutely required. PglL of Neisseria
is not located adjacent to the pilin structural gene, pilE, and N.
meningitidis and N. gonorrhoeae have general O-glycosylation systems
capable of modifying serine and threonine residues in many
Figure 3. Phenotypic analysis of Acinetobacter baylyi strain
ADP1 candidate PglL O-OTase mutants. Western blot analysis
using a-ComP antibody of wild-type (ADP1), pglL mutant (AD-
P1pglL::kan), pglL mutant complemented with plasmid-borne pglL
(ADP1pglL::kan pWH1266-pglL) and pglL mutant with empty vector
(ADP1pglL::kan pWH1266).
doi:10.1371/journal.pone.0062768.g003
Figure 4. Western blot analysis of putative Neisserial glycoproteins. N. gonorrhoeae MS11pglL::kan, N. gonorrhoeae MS11, N. meningitidis
C311pglL::kan and N. meningitidis C311 whole cell extracts were separated by SDS-PAGE, blotted to nitrocellulose membrane and probed with (A) a-
AniA, (B) a-Laz, (C) a-MetQ, (D) a-Sco, (E) a-Mip or (F) a-CcoP antisera.
doi:10.1371/journal.pone.0062768.g004
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different protein substrates [3,4]. Apart from PilE, which is the
most abundant glycoprotein, the additional substrates are modi-
fied in flexible, low-complexity regions [3,4]. However, the factors
controlling selection of particular sites for glycosylation in these
domains are poorly understood. Our results here show that the
local sequence Ala-Ala-Ser-Ala-Pro found in AniA, in particular
the Pro, allows efficient glycosylation of Ser residues (Fig. 5).
However, in all of the variant proteins examined, extremely low
Figure 5. Glycosylation status of purified AniA-FLAG variants.
Extracted ion chromatograms corresponding to the un- (full) mono-
(dashed) and di- (dotted) glycosylated versions of the Leu358-Lys387
tryptic peptide containing the AniA glycosylation sites: (A) wild type,
(B) S373A, (C) S378A, (D) S373A, S378A, (E) S373A, S378A, S385P.
Corresponding variant sequences are shown in Table S6. (F) Proportion
of un- (white) mono- (gray) or di- (black) glycosylated versions of each
variant shown in (A)–(E), as determined by integration of extracted ion
chromatograms. Values are mean, error bars show s.e.m. *, P=0.01 2-
sided Mann-Whitney test.
doi:10.1371/journal.pone.0062768.g005
Figure 6. Structures of PglL acceptor substrate proteins. (A) CD
Spectrum of AniA C-terminal peptide (NGAAPAASAPAASAPAASA-
SEKSVY). Peptide was analysed in 50 mM KH2PO4 with 0–50% of TFE.
(B) The difference in CD spectra between the peptide in 50% TFE and
no TFE. (C) Modelling of N. meningitidis PilE glycosylation site structure.
Peptide corresponding to the glycosylated region of C311 PilE
(57WPGNNTS(Gal(b1–4)Gal(a1–3)2,4-diacetimido-2,4,6-trideoxyhexo-
se)AGVASSSTIK73) constrained as in the structure of N. gonorrhoeae PilE
was modelled.
doi:10.1371/journal.pone.0062768.g006
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levels (,1%) of glycosylation at additional sites were repeatedly
detected (Fig. 5). This suggested that PglL does not recognize a
strictly defined ‘sequon’, but rather glycosylates Ser residues with
different efficiencies or rates depending on the local sequence or
structural environment. Comparison of the AniA and PilE
glycosylation sites reveals that only the primary amino acid
sequence Ser(glycan)-Ala is common. This sequence is unlikely to
define the PglL substrate, as the same sequence occurs in many
other non-glycosylated proteins, and also in other, non-glycosy-
lated regions of AniA and PilE. The pilin target serine is in a
surface loop, on a section that contains a short a-helix (Fig. 6C,
and [23]). Secondary structure may therefore be a key aspect of
PglL substrate specificity. This is supported by our in vitro CD
spectroscopy and in vivo mutagenesis analysis of AniA glycosylation
acceptor sites. CD spectroscopy of the AniA peptide in solution
with TFE suggested that this peptide samples conformations that
contain regular helical structures (Fig. 6). Further, the proline
residues proximal to glycosylated serines in AniA (Fig. 5) may
temporarily introduce the local structure required for efficient
glycosylation. This may be similar to peptide substrate binding
shown in the X-ray structure of the Campylobacter lari N-OTase
[33], where the ‘N-glycosylation sequon’ (D/E-x-N-z-S/T) [5] is
not required for catalysis, but rather for protein acceptor
recognition. The requirement that N. meningitidis PglL substrates
have a turn immediately C-terminal to the serine to be
glycosylated may be due to specific interactions resulting in
increased acceptor protein binding affinity, or spatial constraints at
the O-OTase active site. This is consistent with this polypeptide
sequence binding to PglL with an induced fit mechanism, or that
the proline adjacent to the target sites key for glycosylation in AniA
may give rise to local temporary turns mimicking the constrained
loop in PilE.
It has been shown that purified PglL protein can be used in
in vitro assays to glycosylate substrate protein in the presence of
solubilized glycan-pyrophosphate-undecaprenyl as donor glycan
substrate [34]. In these in vitro assays, the N. gonorrhoeae O-OTase
could glycosylate purified PilE protein, but could not glycosylate a
short peptide containing the glycosylation site and surrounding
residues. This is in agreement with our data, consistent with local
structural conformation rather than sequence being key to
recognition by the PglL O-OTase. Interestingly, an unrelated
class of bacterial cytoplasmic O-glycosyltransferases also recognize
a structural motif in its protein acceptor substrates [35]. In all
Neisserial glycoproteins except for PilE, glycosylation occurs in
flexible linker extensions that are N- or C-terminal or linking two
domains [4]. Such extensions would be likely to minimally impact
protein folding and function, and as such would not have large
evolutionary barriers. It is likely that these factors have allowed the
Neisserial glycosylation system to evolve from an ancestral targeted
system that modified the single abundant PilE substrate, to a
general system with substrates that contain flexible N-, internal or
C-terminal extensions that are local structural mimics of the PilE
glycosylation site. Efficient glycosylation of only folded PilE by
PglL [34] implies that glycosylation in vivo in the Neisseria most
likely occurs only after protein folding. This is in contrast to the
distantly homologous system of N-glycosylation by bacterial N-
OTase, which glycosylates asparagines in unfolded polypeptide or
flexible regions of folded proteins [36]. N-OTase is generally
coupled to polypeptide translocation to access unfolded protein
substrate [37], and this contrast suggests that PglL may have a
different sub-compartmental localisation which allows efficient
post-folding glycosylation of proteins including PilE, AniA, Sco,
CcoP and Mip, but which allows only limited modification of
other substrates including MetQ and Laz. Sco, CcoP and Mip are
periplasmic, and as such may have prolonged access to PglL,
allowing efficient glycosylation. In contrast, MetQ, Laz and AniA
are outer membrane proteins, and so must be glycosylated by PglL
before transport from the periplasm to the outer membrane.
Efficient modification of AniA may be due to the C-terminal
position of its flexible glycosylated domain, in contrast to the N-
terminal flexible domains of MetQ and Laz. Additional factors
including protein-specific secretion rate or subcellular targeting
may also be important in controlling the efficiency of glycosylation
of particular proteins. We note that previous reports characterising
the glycosylation system of N. gonorrhoeae [4] relied on MS
identification of enriched glycoproteins and an ex vivo E. coli
expression system to identify PglL substrate proteins. As such,
differences in efficiency of glycosylation were not distinguished.
During the preparation of this manuscript seven additional
putative glycoproteins were reported from N. gonorrhoeae using a
glycan-specific enrichment and MS identification strategy [38].
Subsequent analysis of His-tagged versions of these putative
glycoproteins expressed in N. gonorrhoeae revealed that many of
these proteins were essentially unmodified, as we also observed in
the current study (Fig. 4) for several other candidate glycoproteins
reported by the authors in a previous study [4]. These stark
differences in the glycosylation efficiency of the various putative
Neisserial glycoproteins were not discussed by the authors [38].
However, their data and our current study emphasize the
importance of studying the native organism using a range of
complementary analytical techniques in determining if a protein is
efficiently glycosylated, and thereby appropriately defined as a
glycoprotein, rather than being a minor or accidental substrate
only identified by very sensitive glycan-specific enrichment and
MS detection.
The ability of the O-glycosylation system of the pathogenic
Neisseria to modify many protein substrates may be related to the
need to physically unlink the genes encoding PglL and the pilus
biogenesis machinery. The pilE gene of Neisseria is highly
antigenically variable and the system that promotes antigenic
variation in pilE, by high levels of homologous recombination
between pilE and non-expressed copies of the gene pilS, is
dependent on the context of the pilE gene for efficient
recombination between pilE and pilS [39]. There may therefore
have been selective pressure for the pglL gene to be located distally
from the pilE gene in Neisseria. The close genomic location of pglL
and substrate glycoprotein in many bacteria likely confers
efficiency to the glycosylation machinery. Non-linked pglL would
therefore likely require increased protein acceptor substrate
recognition or alternative substrate targeting mechanisms. Such
features of efficient protein substrate selection, other than genomic
location, could then allow the evolution of efficient glycosylation
sites in many proteins. Unlike sequon-based recognition in general
N-glycosylation systems [5,36,40], structural features dominate
recognition of protein substrates in the general Neisserial O-linked
glycosylation system.
Supporting Information
Figure S1 Peptide mapping coverage of Azurin (NMB_1533)
after IP with a-glycan antisera. Peptides identified with p,0.05
(ions score .23) are underlined.
(TIF)
Figure S2 Peptide mapping coverage of PilE (NMB_0018) after
IP with a-glycan antisera. Peptides identified with p,0.05 (ions
score .23) are underlined.
(TIF)
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Figure S3 Peptide mapping coverage of MetQ (NMB_1946)
after IP with a-glycan antisera. Peptides identified with p,0.05
(ions score .23) are underlined.
(TIF)
Figure S4 N. meningitidis AniA glycosylation (A) Cartoon of
domains of N. meningitidis AniA protein showing: lipid-anchored N-
terminal cysteine; N-terminal flexible region; AniA core fold;
glycosylated C-terminal flexible region; D, truncated variant at
Met354. (B) Western blots of FLAG-tagged purified AniA: wild
type and C-terminally truncated (at Met 354, D in (A)), detected
with either anti-FLAG or anti-glycan antisera.
(TIF)
Figure S5 750 MHz NMR spectra of the AniA glycosylation
peptide in increasing concentrations of TFE-d6 (in 20 mM KPi,
pH 6.5). The amide and aromatic region is shown (6.6–8.6 ppm).
Increasing TFE-d6 results in upfield and downfield shifts of amide
resonances. The shift of V389 and Y390 are shown dashed.
(TIF)
Table S1 Peptide sequences used for conjugate to Keyhole
Limpet Hemocyanin to raise protein-specific antisera.
(PDF)
Table S2 Proteins identified from N. meningitidis after IP with a-
glycan antisera.
(PDF)
Table S3 Peptides identified from Azurin (NMB_1533) after IP
with a-glycan antisera with p,0.05 (ions score .23).
(PDF)
Table S4 Peptides identified from PilE (NMB_0018) after IP
with a-glycan antisera with p,0.05 (ions score .23).
(PDF)
Table S5 Peptides identified from MetQ (NMB_1946) after IP
with a-glycan antisera with p,0.05 (ions score .23).
(PDF)
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